Galafold® (migalastat)
for Fabry Disease

Galafold (migalastat) is an oral treatment for Fabry disease in adults with amenable genetic variants. It works by binding to and stabilizing the alpha-galactosidase A enzyme, which is deficient or unstable in Fabry disease. By stabilizing this enzyme, Galafold helps it function correctly, preventing the buildup of harmful fatty substances in the body and reducing disease complications.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Fabry Disease